Search

Issue
Title
Authors
Vol 31, No 2 (2024)
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
PDF
(Rus)
Vol 30, No 12 (2023)
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Demidov N.A.
PDF
(Rus)
Vol 27, No 4 (2020)
Individual drugs associated with overweight inducing
Ostroumova O.D., Sapozhnikova Y.I., Kochetkov A.I., Starodubova A.V.
PDF
(Rus)
Vol 26, No 14 (2019)
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
PDF
(Rus)
Vol 29, No 11/12 (2022)
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Dukhareva O.V., Demidov N.A., Novikova M.S.
PDF
(Rus)
No 11 (2018)
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G.R., Antsiferov M.B., Alekseeva Y.G.
PDF
(Rus)
No 5 (2013)
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
PDF
(Rus)
Vol 29, No 11/12 (2022)
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E.
PDF
(Rus)
No 16 (2017)
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.B.
PDF
(Rus)
No 16 (2012)
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M.B., Galstyan G.R.
PDF
(Rus)
Vol 28, No 4 (2021)
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A.E., Shchukina E.V., Efremenko V.A., Mikhailichenko E.S., Suprun E.V.
PDF
(Rus)
No 16 (2017)
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.V.
PDF
(Rus)
No 11 (2012)
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
PDF
(Rus)
No 5 (2017)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
PDF
(Rus)
No 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
No 5 (2016)
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O.M., Molina L.P.
PDF
(Rus)
No 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M.B., Zilov A.V., Antsiferov M.B., Zilov A.V.
No 5 (2016)
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.V.
PDF
(Rus)
No 5 (2015)
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N.A., Ivanova L.P., Abaeva F.T.
PDF
(Rus)
No 5 (2015)
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
PDF
(Rus)
1 - 20 of 20 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies